OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
08 mars 2023 08h00 HE
|
OPKO Health, Inc.
MDX-2201 leverages ModeX’s innovative biologics platform to target multiple Epstein-Barr virus (EBV) proteinsEBV is the leading cause of infectious mononucleosis and is also associated with some...
OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results
23 févr. 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, Feb. 23, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2022. Business highlights include...
OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
16 févr. 2023 11h41 HE
|
OPKO Health, Inc.
MIAMI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2022 after the close of the U.S....
OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 janv. 2023 08h00 HE
|
OPKO Health, Inc.
MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41st Annual J.P. Morgan Healthcare Conference being held January...
OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results
08 nov. 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, Nov. 08, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2022. Business highlights for the...
OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022
01 nov. 2022 08h00 HE
|
OPKO Health, Inc.
MIAMI, Nov. 01, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2022 after the close of the...
OPKO Health Announces Leadership Changes for BioReference Laboratories
16 août 2022 16h29 HE
|
OPKO Health, Inc.
MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced that Jon R. Cohen, M.D., is retiring from his...
OPKO Health Reports 2022 Second Quarter Business Highlights and Financial Results
04 août 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, Aug. 04, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2022. Business highlights...
OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022
25 juil. 2022 16h05 HE
|
OPKO Health, Inc.
MIAMI, July 25, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2022 after the close of the U.S....
OPKO Health to Present at the 2022 Jefferies Healthcare Conference
02 juin 2022 08h00 HE
|
OPKO Health, Inc.
MIAMI, June 02, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 2022 Jefferies Healthcare Conference taking place June 8-10,...